Review of toxicity studies of carbon nanotubes

Abstract

Objective: We reviewed studies on pulmonary, reproductive, and developmental toxicity caused by carbon nanotubes (CNTs). In paricular, we analyzed how CNT exposure affects the several processes of pulmonary toxicity, including inflammation, injury, fibrosis, and pulmonary tumors. Methods: In pulmonary toxicity, there are various processes, including inflammation, injury, fibrosis, respiratory tumor in the lungs, and biopersistence of CNTs and genotoxicity as tumor-related factors, to develop the respiratory tumor. We evaluated the evidence for the carcinogenicity of CNTs in each process. In the fields of reproductive and developmental toxicity, studies of CNTs have been conducted mainly with mice. We summarized the findings of reproductive and developmental toxicity studies of CNTs. Results: In animal studies, exposure to CNTs induced sustained inflammation, fibrosis, lung cancer following long-term inhalation, and gene damage in the lung. CNTs also showed high biopersistence in animal studies. Fetal malformations after intravenous and intraperitoneal injections and intratracheal instillation, fetal loss after intravenous injection, behavioral changes in offsprings after intraperitoneal injection, and a delay in the delivery of the first litter after intratracheal instillation were reported in mice-administered multi-walled carbon nanotubes (MWCNTs). Single-walled carbon nanotubes (SWCNTs) appeared to be embryolethal and teratogenic in mice when given by intravenous injection; moreover, the tubes induced death and growth retardation in chicken embryos. Conclusion: CNTs are considered to have carcinogenicity and can cause lung tumors. However, the carcinogenicity of CNTs may attenuate if the fiber length is shorter. The available data provide initial information on the potential reproductive and developmental toxicity of CNTs.

Introduction

Industrial nanomaterials have many outstanding physical and chemical properties due to the advancement in nanotechnology; their applications and uses in various fields are being explored all over the world. Among these industrial nanomaterials, carbon nanotubes (CNTs), an industrial nanomaterial, are fibrous materials formed from honeycomb crystal lattice layers of graphite wrapped into a tube shape either as a single layer or as multiple layers, which are respectively called single-walled carbon nanotubes (SWCNTs), and multi-walled carbon nanotubes (MWCNTs). These CNTs are used in semiconductors, solar cell mobiles, optical instruments, capacitors, and the cables of the space elevator, making use of CNT's special qualities. However, the other properties of CNTs are reported to have harmful effects on the human body. Compared with micron-sized carbon-based particles, exposure of CNTs induced pulmonary inflammation at a smaller dose in animal studies^1,2). The inhalation exposure of CNTs induced malignant mesothelioma in animal studies³⁾, suggesting that CNTs may pose hazards similar to asbestos. Damage to other organs due to pulmonary exposure to CNTs has also been reported in animal studies^4,5). Some studies have reported that maternal exposure to CNTs may induce developmental toxicity, such as teratogenicity⁶⁾. Here, we review the toxicity of CNTs, particularly as related to pulmonary toxicity, reproductive and developmental toxicity.

Pulmonary Toxicity

Malignant tumors such as lung cancer and mesothelioma are considered to be important target diseases to evaluate the pulmonary toxicity of respirable materials. The process of the development of malignant tumors, especially in lung cancer, induced by respirable insoluble materials is generally considered to be as follows^7,8). When respirable materials are inhaled in the lungs and are phagocytized by alveolar macrophages, inflammatory cytokines and chemokines are released by alveolar macrophages, and repeated exposure of respirable materials in the lungs induces persistent inflammation and damage^9,10). Persistent inflammation and damage finally lead to pulmonary fibrosis and respiratory cancer due to surplus or abnormal repair processes^7,8). Therefore, we mainly evaluated the persistency of inflammation and injury, the findings on repair disorder and fibrosis, the incidence of tumor in the respiratory system, and the biopersistance of CNTs as related factors in the pulmonary toxicity of CNTs. Among the different types of pulmonary toxicology studies following each part, inhalation studies are considered to provide us particularly important information about the pulmonary toxicity of respirable chemicals because the physiological exposure route is similar to that of occupational exposure in humans.

1) Inflammation in respiratory system

Persistent pulmonary inflammation is observed in most intratracheal instillation and inhalation studies of CNTs, although only transient or no inflammation in the lungs is observed in some studies of CNTs (Table 1).

Table 1. Summary of pulmonary toxicity studies on CNTs

Exposure route	CNT type	Characterization	Animal	Concentration /dose	Post-exposure observation period	Findings	References
Inhalation	MWCNTs (mixture of MWCNTs and graphitic nanofibres)	Size: 10-20 nm×5-15 μm Impurities: 0.5% Ni and Fe Surface area: 100 m2/g MMAD: 700-1000 nm/1800 nm	Male C57BL/6 mouse	0.3, 1, 5.3 mg/m3, 7 and 14 days, 6 h/day	0 day	No local pulmonary effects. Non-monotonic　systemic immune suppression	Mitchell et al. (2007)11)
				0.3, 1 mg/m3, 14 days; 6 h/day	0 day	Systemic immune suppression, not due to systemic uptake of MWCNT, but due to release of immune suppressing signals from the lung	Mitchell et al. (2009)12)
Inhalation	MWCNTs	Size: 5-15 nm×0.1-10 μm Impurities: 10% metal oxide Surface area: 250-300 m2/g MMAD: 0.5-1.3 μm	Wistar rat	2, 8, 32 mg/m3, 5 days, 6 h/day	3, 24 day	Increase in BALF total cell counts, protein content, enzyme activities	Ma-Hock et al. (2009)13)
Inhalation	MWCNT	Co 0.46-0.53% BET 253 m2/g Range of length: 200-300nm	Wistar rat male, female	0.1, 0.4, 1.5, 6 mg/m3, 13 week	6 months	Inflammation at 0.4 mg/m3 (transient) 1.5 mg/m3 (persistent) 6 mg/m3 (persistent)	Pauluhn (2010)14)
Inhalation	Carbon nanofiber	Carbon>99.5% Diameter 158 nm Length 5.8 μm BET 13.8 m2/g	SD rat male, female	0.54 mg/m3 (4.9f/cc) 2.5 mg/m3 (56f/cc) 25 mg/m3 (252f/cc) 13 weeks	90 days	Persistent inflammation at 25 mg/m3	DeLorme et al. (2012)15)
Inhalation	MWCNT	Diameter 44 nm BET 69 m2/g Fe 0.0005%	Wistar rat male	0.37 mg/m3 (>70% individual) 4 weeks	3 months	No inflammation, no fibrosis	Morimoto et al. (2012)16)
Inhalation	SWCNT	Diameter 3 nm BET 1064 m2/g Impurities 0.03%	Wistar rat male	0.03 mg/m3 (5＊104/cc) 0.13 mg/m3 (6.6＊104/cc) 4 weeks	3 months	No inflammation, no fibrosis	Morimoto et al. (2012)17)
Inhalation	MWCNTs	Size: 94.1-98 nm×5.53-6.19 μm Impurities: >99.6-99.8% purity Surface area: 24-28 m2/g MMAD: 1.4-1.6 μm	Male and female F344 rat	0, 0.2, 1, 5 mg/m3, 13 weeks 5 days/week 6 h/day	0 day	Increase in lung weights, BALF inflammatory parameters. Granulomatous changes, focal fibrosis of the alveolar wall, inflammatory infiltration in the visceral pleural and subpleural areas was observed.	Kasai et al. (2015)18)
Intratracheal instillation	SWCNT	nominal diameter 1.4 nm, length >1μm, agglomerated rope ~30 nm	CD rat male	1 mg/kg, 5 mg/kg	3 months	Transient inflammation	Warheit et al. (2004)19)
Intratracheal instillation	MWCNT	CNT: length 5.9 μm Ground CNT: length 0.7 μm	SD rat female	0.5, 2, 5 mg/rat	60 days	Inflammation (until 15 days) and granuloma	Muller et al. (2005)20)
Intratracheal instillation	SWCNTs	Size: 1-2 nm×several μm (No exact characterization)	Male ICR mice	0.5 mg/kg	3, 14 days	Release of cytokines (NF-κB)	Chou et al. (2008)21)
Intranasal instillation	Purified DWCNTs (80% DWCNTs, 20% SWCNTs)	Size: 1.2-3.2 nm×1-10 μm (bundles up to 100 μm)	Male Swiss mice	1.5 mg/kg	6, 24, 48 h	Local and systemic inflammation. No increase in TNF-α．Decrease in local oxidative stress	Crouzier et al. (2010)22)
Intratracheal instillation	MWCNTs	Size: 20-50 nm×0.5-2 μm, Impurities: >95% purity Surface area: 280 m2/g	Male Sprague- Dawley rat	1, 10, 100 μg/rat	1, 7, 30, 90, 180 days	No inflammation, apoptosis of macrophages having phagocytosed MWCNTs (elimination)	Elgrabli et al. (2008)23)
Intratracheal instillation	MWCNTs	Size: 11-170 nm×5-9 μm Impurities: >90% carbon Surface area: 12.83 m2/g	ICR male mouse	5, 20, 50 mg/kg	1, 3, 7, 14 days	Increase in immune cells. Increase in proinflammatory cytokines (IL-1, TNF-α，IL-6, IL-4, IL-5, IL-10, IL-12, IFN-γ) and IgE. Distribution of B cells in spleen,	Park et al. (2009)24)
Intratracheal instillation	MWCNT	Diameter 88 nm Length 5 μm Fe 0.44%	F344 rat male	40 μg/rat 160 μg/rat	91 days	Persistent inflammation and fibrosis	Aiso et al. (2010)25)
Intratracheal aspiration	MWCNT	Diameter 31nm Length 20μm BET 50 m2/g Impurity 3.5 wt%	C57BI mice female	20 μg/mouse 40 μg/mouse	7 days	Transient inflammation	Han et al. (2010)26)
Intratracheal instillation	MWCNTs	Size: 60 nm×1.5 μm Impurities: 99.79% carbon (7-8% carbon soot) Surface area: 23.0 m2/g	Male Sprague- Dawley rat	0.04, 0.2, 1 mg/kg	3, 7, 28, 91 days	Increase in BALF neutrophils, eosinophils, LDH, and TP levels increased. BALF cytokine levels not changed.	Kobayashi et al. (2010)27)
Intratracheal instillation	SWCNTs	Size: 12 nm×0.32 μm Impurities: 0.05% total metal Surface area: 1064 m2/g	Male Sprague- Dawley rat	0.04, 0.2, 1, 2 mg/kg	1, 3, 7, 28, 91, 182 days	Increase in BALF neutrophils, macrophages, lymphocytes, eosinophils, LDH, protein, and IL-1β，IL-6.	Kobayashi et al. (2011)28)
Intratracheal instillation	MWCNT	Diameter 44 nm BET 69 m2/g Fe 0.0005%	Wistar rat male	0.66 mg/kg 3.3 mg/kg	6 months	Inflammation at 0.66mg/kg (transient) 3.3mg/kg (persistent) Transient fibrosis	Morimoto et al. (2012)16)
Intratracheal instillation	SWCNT	Diameter 1.8 nm BET 878 m2/g	Wistar rat male male	0.66 mg/kg 1.32 mg/kg	6 months	Persistent inflammation Minimum fibrosis	Morimoto et al. (2012)29)
Pharyngeal aspiration	SWCNT	Diameter 1-4nm Length 1-3 μm BET 1040 m2/g	C57BL/6 mice, female	40 μg/mouse	28 days	Persistent inflammation and granuloma	Murray et al. (2012)30)
Intratracheal	SWCNT	BET 877.7 m2/g Diameter 44 nm	Wistar rat male	0.2 mg/rat 0.4 mg/rat	754 days	granuloma (+) → (-) 365 and 754days	Fujita et al. (2015)31)
Pharyngeal aspiration	MWCNTs	Size: 49 nm×3.86 μm Impurities: 0.78% total metals	Male C57BL/6J mouse	10, 20, 40, 80 μg/mouse	1, 7, 28, 56 days	Increase in BAL PMNs, LDH, albumin. Persistent inflammation Progressive fibrosis at 80 μg	Porter et al. (2010)32) Mercer et al. (2011)33)
Pharyngeal aspiration	Purified SWCNTs	Size: 1-4 nm Impurities: 0 .23% Fe Surface area: 1040 m2/g	Female C57 BL/6 mouse	0, 10, 20, 40 μg/mouse (0, 0.5, 1, 2 mg/kg)	1, 3, 7, 28, 60 days	Inflammation (TNF-α and IL-1β increased). Persistent inflammation and fibrosis	Shvedova et al. (2005)34)
Pharyngeal aspiration	Purified SWCNTs	Size: 1-4 nm Impurities: 0.23% Fe Surface area: 1040 m2/g	Female C57 BL/6 mouse	0, 40 μg/mouse (0, 1.9 mg/kg)	1, 3, 7, 28 days	Robust, acute inflammation (PMNs, TNF-α，IL-6, LDH increased).	Shvedova et al. (2007)35)
Pharyngeal aspiration	SWCNTs	Size: 0.8-1.2 nm×100-1000 nm Impurities: 17.7% Fe Surface area: 508 m2/g	Female C57 BL/6 mouse	0, 5, 10, 20 μg/mouse (0, 0.25, 0.5, 1 mg/kg)	1, 3, 7, 28 days	Inflammation (TNF-α，IL-6 and TGF-β increased) GSH depletion, lipid peroxidation, oxidised proteins	Shvedova et al. (2008)36)
Pharyngeal aspiration	DWCNT	Diameter 1-2 nm Length<5 μm	C57BL/6 mice male	1,10,40 μg/mouse	56 days	Persistent alveolitis and interstitial fibrosis at 10 μg and 40 μg	Sager et al. (2013)37)

Some inhalation studies of CNTs with pulmonary inflammatory endpoints showed a tendency of pulmonary inflammation induced by low concentrations of CNT.

Four 13-week inhalation studies in rats^13,14,18,38) of three types of MWCNTs and one MWCNT with a function of high strength, showed that exposure to MWCNTs and carbon nanofibers (CNFs) induced persistent inflammation with no-observed-adverse-effect-level (NOAEL) between 0.1 mg/m³ and 0.25 mg/m³ and with lowest-observed-adverse-effect-level (LOAEL) at 0.2 mg/m³. In two of these four studies^14,38), high concentration of MWCNTs showed sustained inflammation in the lungs during the observation periods. Two four-week inhalation studies of MWCNTs and SWCNTs showed no inflammation in the rats' lungs with maximum concentrations of 0.37 mg/m³ and 0.13 mg/m³, respectively^16,17). The length of CNTs used in both studies was relatively short (mean length was 1 μm or less). One six-hour inhalation study of MWCNTs at a concentration of approximately 30 mg/m³ did not show neutrophil influx in the lungs³⁹⁾.

Many intratracheal instillation and pharyngeal aspiration studies of CNTs have been reported^{16,19,20,25-29),32,34,37,40)}. Similar to the inhalation studies, most studies showed that exposure to SWCNTs and MWCNTs induced persistent pulmonary inflammation, while some studies showed only transient pulmonary inflammation³⁹⁾. Compared with short fibers, long fibers induced more pronounced pulmonary inflammation^41-43), although short fibers of CNTs also induced persistent pulmonary inflammation¹⁶⁾. It has been reported that the type of CNTs is related to the location of inflammation even if the length of a CNT is short⁴⁴⁾. Fujita et al. (2016)⁴⁴⁾ examined the difference in inflammation between short SWCNTs and MWCNTs in the respiratory system following intratracheal instillation. They showed that exposure to SWCNTs caused persistent pulmonary inflammation, while exposure to MWCNTs caused transient pulmonary inflammation and later induced greater level of pleural inflammation.

Taken together from the inhalation and the intratracheal instillation studies, both MWCNTs and SWCNTs are considered to induce persistent pulmonary inflammation in experimental animals. However, pulmonary inflammation induced by short fibers tend to be less persistence than that induced by long fibers in intratracheal instillation studies.

2) Injury in respiratory system

The proliferation of epithelial cells is one of the usual physiological responses after lung injury resulting from stimulation by a foreign material. The finding of proliferation corresponds to lung injury, although it is a compensatory response. When the stimulant is totally removed, cell proliferation ends. On the contrary, persistent proliferation indicates physiological responses by persistent stimulation or change of the phenotype of cell response, such as an autonomous responses.

Some studies have found the proliferation of bronchiolar and alveolar epithelial cells after exposure to CNTs, although some studies have not.

In two 13-week inhalation studies^14,15), exposure to MWCNTs at a concentration of 6 mg/m³ (probably more than overload dose due to delayed clearance of MWCNTs) induced hyperplasia in the bronchiole/alveolar area at 39 weeks after inhalation. MWCNT concentrations of 1.5 mg/m³ or less did not induce hyperplasia. Exposure to carbon nanofibers stimulated only transient proliferation of the terminal bronchiole, alveolar duct, and the subpleural region in the lungs of male and female rats.

Two intratracheal instillation studies of MWCNTs showed lung injury^45,46). One study using proliferating cell nuclear antigen (PCNA) immunolabeling showed that exposure to pristine or functionalized MWCNTs stimulated the proliferation of alveolar and bronchiolar epithelial cells, although the observation period (16 days) was not long enough to evaluate the persistency of hyperplasia. The other study showed that oropharyngeal aspiration of MWCNTs caused alveolar hyperplasia of type 2 pneumocytes at 5 weeks after the end of the exposure period, although it is not the bronchoalveolar area that is the origin of lung cancer. In another intratracheal instillation study¹⁹⁾, SWCNT exposure did not induce the proliferation of lung parenchymal cells by 5-bromo-2-deoxyuridine (BrdU).

Xu et al. (2012)⁴⁷⁾ conducted an intratracheal instillation using a special spray-type cannula. As per the findings of their study, exposure to MWCNTs induced visceral mesothelial cell proliferation, although it is not the parietal pleura where malignant mesothelioma originates.

Summarized collectively, inhalation and intratracheal instillation studies of MWCNTs and SWCNTs, the evidences on persistent hyperplasia of bronchoalveolar epithelial cells was not sufficient.

3) Fibrosis in respiratory system

Pulmonary fibrosis is regarded as surplus or abnormal repair after lung injury. It is unknown whether pulmonary fibrosis and fibrosis-related factors caused by exposure to CNTs directly affect the transformation and proliferation of normal epithelial cells to cancer cells. However, Chang et al. (2012)⁴⁸⁾ reported that SWCNT-induced pulmonary fibrosis in mice was associated with epithelial-mesenchymal transition, namely epithelial cell derived fibrosis with the function of collagen production. Pulmonary fibrosis, such as idiopathic pulmonary fibrosis is accompanied by lung cancer at a high frequency⁴⁹⁾. In chronic inhalation studies of asbestos and man-made vitreous fibers, fibers that induced pulmonary fibrosis developed into pulmonary tumor⁵⁰⁾. Therefore, the fibrosis and fibrosis-related factors induced by exposure to CNTs may affect the transformation and proliferation of epithelial cells. We consider that the finding of pulmonary fibrosis induced by CNTs is related to tumor-related factors.

Table 1 shows results of inhalation and intratracheal instillation studies. Most of these studies showed pulmonary fibrosis and most of the CNT-exposed groups with the finding of fibrosis in inhalation and intratracheal instillation studies corresponded to CNT-exposed groups with persistent pulmonary inflammation. Compared with short fibers, needle-like long fibers in both studies tended to induce fibrotic responses such as fibroblast proliferation and collagen deposition^42,43). As for the intraperitoneal injection study, long MWCNT exposure led to granulomatous inflammation in the peritoneal cavity but tangled MWCNT showed weak or little responses⁵¹⁾.

4) Biopersistence of CNTs in the lung

Biopersistence of materials in the lungs is how long the materials remain in the lungs. Materials with high biopersistence remain in the lungs for a long time; on the contrary, materials with low biopersistence get quickly cleared from the lungs. Fibrous materials with high biopersistence, such as asbestos and ceramic fibers are reported to cause pulmonary fibrosis and cancer⁵⁰⁾. In other words, if materials remain in the lungs for a long time, they have high probability of causing persistent inflammation and injury in the lungs. CNTs are reported to have high biopersistence. The retention half-times of MWCNTs in the lungs, an index of clearance, at 0.1 mg/m³, 0.4 mg/m³, 1.5 mg/m³, and 6 mg/m³ following a 13-week inhalation exposure of MWCNTs were 151, 350, 318, and 375 days, respectively¹⁴⁾. Although there are differences in the half-times, the authors considered that these delayed times were related to volumetric overload. A twelve-day inhalation study revealed that 65.1% of the total lung burden of MWCNTs at 5 mg/m³ remained in the murine lungs 336 days after inhalation exposure⁵²⁾. Intratracheal instillation of MWCNTs at 0.2 mg and 0.55 mg revealed that the burden of MWCNTs in the lungs did not decrease significantly between 1 day and 364 days after exposure⁵³⁾.

The biopersistence of fibrous materials, including asbestos, is thought to be regulated by length and durability⁵⁰⁾. Long and insoluble fibers are biopersistent because macrophages cannot phagocytize long fibers; furthermore, poor degradation makes the clearance of fiber difficult. While relatively long CNTs were used in the studies mentioned above, some studies did use short CNTs, which showed a relatively short half-time in the lungs. One four-week inhalation study of short MWCNTs (geometric mean length: 1.1 μm) revealed that the biological half-time of MWCNTs at 0.37 mg/m³ was 51-54 days⁵⁴⁾. CNTs with short fibers tend to have shorter half-times than those with long fibers. The length may affect the clearance of materials such as asbestos in the lungs. In asbestos, fibers with length more than 20 μm are reported to have higher biopersistence compared with fibers with a length less than 5 μm⁵⁵⁾.

As for solubility, CNTs are generally thought to be resistant to chemical attack due to their fundamental graphitic structure. The insolubility of MWCNTs and SWCNTs is equal to or higher than asbestos⁵⁶⁾. Therefore, length is an important characteristic in the biopersistence of CNTs. There are a few soluble-type CNTs. These CNTs become shorter due to degradation and are efficiently cleared from the lung, suggesting that a characteristic of CNT is low biopersistence. Osmond-Mcleod et al. (2011)⁵⁶⁾ reported that soluble-type CNTs induced low pathogenic potential.

5) Gene damage in the lung

Gene damage in the lungs is considered to play a key role in the transformation and proliferation of cells (especially epithelial cells) as an abnormality of restoration following lung injury.

Most CNT studies showed the results of genotoxicity in an acute phase following exposure and induced the formation of DNA breakage, micronuclei, and mutations in the lungs after inhalation and intratracheal instillation. Intratracheal or pharyngeal instillation and inhalation of MWCNTs to mice induced DNA strand breaks in the lungs in a dose-dependent manner through the comet assay^57,58). Among studies with gene mutation assays, one study showed that the intratracheal instillation of MWCNTs increased the mutation frequency in the lungs detected by gpt assay⁵⁷⁾. In a study of 10 commercial MWCNTs, the intratracheal instillation of some MWCNTs induced the DNA breaks in the lung⁵⁹⁾, and multiple regression analysis showed that a lower Brunauer-Emmett-Teller surface area or a corresponding larger diameter was associated with increased genotoxicity. On the contrary, some studies did not induce genotoxicity in vivo. An intratracheal instillation of MWCNTs in rats did not induce DNA damage in their lungs⁶⁰⁾, and the inhalation of MWCNTs did not induce DNA double strand breaks (detected by γ-H2AX foci) or micronuclei in blood leukocytes⁵⁸⁾; another study showed that MWCNT did not increase gpt mutation⁶¹⁾. Possibly, the gene damage observed in the acute phase can be restored, and the gene mutation observed in the chronic phase of CNTs is considered gene damage that is not restored. K-ras mutation plays an important role in the signal transduction of epidermal growth factor receptor and is one of the representative oncogenic driver mutations. The pharyngeal aspiration of SWCNTs and CNFs in mice increased the incidence of K-ras oncogene mutations in the lungs at 1 year post exposure⁶²⁾. Four days inhalation of SWCNTs also increased the incidence of K-ras and micronuclei positive cells in the lungs at 1 year post exposure.

As for short fibers, in the intratracheal instillation studies using 10 commercial MWCNTs (Most MWCNTs with less than 1 μm)⁵⁹⁾, none of the exposure of all MWCNTs did not induce DNA breaks in murine lungs at the chronic phase in the comet assay, although there is a transient DNA damage in the acute phase.

Gene damage is also reported to be associated with reactive oxygen species (ROS)^63,64). MWCNTs induced the mutation of hypoxanthine phosphoribosyltransferase (HPRT) genes in Chinese hamster lung fibroblasts through ROS⁶³⁾. SWCNTs induced DNA breakage, micronuclei formation, and ROS production in human peripheral bool lymphocytes; however, these stimulating effects of SWCNTs were inhibited by N-acetylcysteine, which is an antioxidant⁶⁴⁾. The mitochondrial damage caused by MWCNTs leads to ROS production, which may damage the nucleus.

6) Malignant tumor in the respiratory system

There are two inhalation studies demonstrating malignant tumors in the respiratory system; one is a long-term inhalation study and the other is a study of the estimation of cancer-promoting effects^65,66). Both studies showed that CNT induced the onset and the promotion of lung cancer.

A 104-week inhalation study of MWCNTs used males and females at the concentrations of 0 mg/m³, 0.02 mg/m³, 0.2 mg/m³, and 2 mg/m³⁶⁵⁾. Lung carcinoma, mainly bronchioloalveolar carcinoma and combined carcinoma and adenoma were significantly increased in males exposed to 0.2 mg/m³ or more and in females exposed to 2 mg/m³. The NOAEL for the endpoints of respiratory tumor was 0.02 mg/m³. Pleural mesothelioma was not observed.

In another study, carcinogenesis phases were classified into some stages, and there was a test protocol that utilized a two-stage initiation (action of carcinogen) /promotion (promotion of cell growth with existing DNA damage) in order to estimate the carcinogenicity of chemicals⁶⁶⁾. Sargent et al. (2014)⁶⁶⁾ performed a 15-day inhalation study (5 mg/m³, five hours/day) of MWCNTs following the intraperitoneal injection of an initiator, methylcholanthrene (MCA), and found that MWCNTs significantly increased tumor rates (bronchioloalveolar adenomas and adenocarcinoma) in the lung exposed to MCA, suggesting that MWCNTs act as a promoter of carcinogenesis.

In an intratracheal instillation study of MWCNTs that was conducted using a specific spray-type cannula⁶⁷⁾, exposure of MWCNTs induced not only lung tumor but also malignant mesothelioma in a 2-year observation period.

In an intraperitoneal injection study, exposure of short MWCNT did not induce carcinogenic responses⁶⁸⁾.

The MWCNTs used in the studies mentioned above were long, thin fibers (mostly MWCNT-7), and there are no studies following the long-term inhalation of short length CNTs.

7) Discussion and summary of the pulmonary toxicity of CNTs

In the process of lung disorders caused by respirable materials, CNTs induced sustained inflammation, fibrosis, finally increase in tumor rate. The finding of dose-dependent responses between MWCNTs and lung tumor following long-term inhalation, which is similar to the exposure in humans, is significant for the estimation of pulmonary toxicity.

We think that the pulmonary toxicity of CNTs cause pulmonary tumor. Although there are few studies, there are data or suspected data regarding the sustained proliferation of epithelial cells. Fujita et al. (2015)³¹⁾ reported that gene expression by SWCNTs with thin bundles with short linear shapes was strongly associated with cell proliferation by comprehensive gene express analysis. One 13-week inhalation study¹⁴⁾ showed that MWCNT exposure induced hyperplasia of epithelial cells after certain observation periods when the concentration of MWCNTs was high. Frank et al. (2016)⁴⁶⁾ found that the oropharyngeal aspiration of CNT caused alveolar hyperplasia of type 2 pneumocytes at 5 weeks after the end of exposure, although that was not in the bronchoalveolar area, that is the origin of lung cancer. The carcinogenicity of CNTs has been observed in the case of long needle-like structures of CNTs, but If the fiber is shorter, the carcinogenicity of CNTs will be attenuated. Compared with long fibers, the exposure to short CNTs induced less inflammation, fibrosis, and in vivo genotoxicity in the chronic phase.

Pauluhn (2011)⁶⁹⁾ showed that the predicted NOAELs based on volumetric overload threshold was almost the same as the obtained NOAEL (0.1 mg/m³). We think that the onset of lung tumor is at least partially related to the overload of CNTs, because 1) the predicted value of NOAEL by Pauluhn⁶⁹⁾ is not so different to the obtained values of NOAEL in carcinogenicity bioassay studies⁶⁵⁾ and because 2) even if dispersed CNTs are exposed in the lungs, an CNT agglomerates are formed in the lungs due to overstress that gives cells through recognition of excessive volume of CNTs⁶⁵⁾.

Malignant mesothelioma was observed in a 2-year observation period in an intratracheal instillation study of MWCNTs using only a spray type cannula, but not in any inhalation studies of MWCNT. We speculate that the use of spray type cannula for intratracheal instillation induced the transfer of MWCNTs into the pleural space much more efficiently compared than in inhalation studies. It has been reported⁴⁷⁾ that intratracheal injection using spray-type cannula make CNTs translocate into the pleura space at short periods. Xu et al. (2012)⁴⁷⁾ found CNTs and crocidolite in the pleural cavity after nine days following the first intratracheal instillation. It is not known whether CNTs directly penetrate into the pleural space or move into the pleura through lymph nodes. There may be differences in the clearance patterns of CNTs between inhalation studies and intratracheal instillation studies using spray type cannula. How these responses are evaluated as pulmonary toxicity is another issue for future studies.

As the carcinogenicity of CNTs is based on animal studies only, their carcinogenicity for humans must also be examined. In future research, we should consider the physicochemical properties of CNTs in work environments and human data. These also are topics for future studies.

8) Reproductive and developmental toxicity

Table 2 shows the significant effects on fetal development as reported in toxicity studies performed on rodents. Reproductive and developmental toxicity studies of CNTs have been conducted mainly with mice.

Table 2. Summary of reproductive and developmental toxicity studies on CNTs in rodents

Exposure route	CNT type	Characterization	Animals	Exposure day	Dose	Findings	References
Iintravenous injection	MWCNT	COOH-MWCNTs (D: 20-30 nm, L: 0.5-2.0 mm); NH4-MWCNTs (D: 20-30 nm, L: 0.5-2.0 mm) in PBS with 0.1% Tween 80	BALB/c mouse(4-8/group)	Once or every 3 d, 5 times	5 mg/kg	Transient histopathological changes in the testes after multiple injections of both MWCNTs; transiently increased levels of MDA in the testes after multiple injections of COOH-MWCNTs No effect on reproductive outcomes when mated with untreated females	Bai et al. (2010)70)
Intraperitoneal injection	MWCNT	NM-400, D: 10 nm, L: 295 nm, 5.3% Al, 0.4% Fe, 0.2% Co, highly bent (Nanocyl, Belgium) in water with 2% mouse serum	C57BL/6JBomTac mouse(30/group)	One day preconception	67 mg/d	Increased lag in delivery of the first litter; long-lasting pathological changes, mononuclear infiltration, and bronchiole sub-epithelial edema in the lungs and an increased number of Kupffer cells and hyperplasia and hypertrophy of Kupffer cells in the liver No effect on maternal body weight gain or gestational or litter parameters, nor offspring open field activity, acoustic startle response, DSP, or testes weight in male pups	Hougaard et al. (2013)71)
Intraperitoneal injection	MWCNT	MWNT-7, width: 100 nm, 27.5%4longer than 5 mm (MITSUI, Japan) in 2% CMC-Na solution	CD1 mouse (6-16/group)	GD 9 (vaginal plug¼GD 0)	2, 3, 4, 5 mg/kg	Increased maternal spleen weight at doses of 2, 3, 4, and 5 mg; resorption rate at 4 and 5 mg; maternal incidence of fetuses with external malformations at 4mg and skeletal malformations at 2mg and higher Decrease in maternal body weight at 4 and 5 mg; litter size at 4 and 5 mg; Fetal weight at 2, 3, 4 mg	Fujitani et al. (2012)72)
Intratracheal instillation	MWCNT			GD 9	3, 4, 5 mg/kg	Increased maternal lung weight at a dose of 5 mg; dams had fetuses with external and skeletal malformations at 4 and 5 mg Decrease in maternal body weight at 5 mg; fetal weight at 5mg
Intraperitoneal injection	MWCNT	D: 30 nm, L: 10 mm, SSA: 270m2/g, 95% C (Research Institute of Petroleum Industry, Tehran, Iran) in PBS	NMR1 mouse (10/group)	Mating day and GD 3	1, 10 mg/d	Increased time in the closed arm of elevated plus-maze and floating period in forced swimming test at a dose of 1mg No deaths or changes in clinical signs of toxicity or reproductive parameters in dams No external malformations or changes in developmental landmarks, reflex ontogeny, or behavior in the open field or Morris water maze	Ivani et al. (2012)73)
Intraperitoneal injection	MWCNT	PL-PEG-NH4-MWCNT-8 (D: 58 nm, L: 0.5-2 mm); PL-PEG-NH4-MWCNT-20 (D: 20-30 nm, L: 0.5-2 mm); PL-PEG-NH4-MWCNT-50 (D: 50 nm, L: 0.5-2 mm) in water PL-PEG-NH4-MWCNT-50 in water PL-PEG-NH4-MWCNT-50 in water 64Cu-labeled PL-PEG-NH4-MWCNT-8, 20, 50 in water	p53+/- mouse (4-6/group)	GDs 10.5, 12.5, 15.5 DG 10.5 or 15.5 GD 15.5	2 mg/kg/d 2 or 5 mg/ kg/d 5 mg/kg	Increase fetal brain defect (50% of p53+/- fetuses) after injection on GD 10.5, fetal brain deformity after injection of PLPEG-NH4-MWCNT-50, nuclear DNA damage in fetal Liver and placenta (p53+/- fetuses were more vulnerable than p53+/- and p53+/+) Decrease in maternal body weight and fetal body weight after injection of PL-PEG-NH4-MWCNT-20 and 50, survival rate of postnatal offspring at 5 mg, body weight of p53+/+fetuses after injection on GD 15.5, brain defect in p53+/- fetuses after coinjection of NA on GD 10.5 Distribution of MWCNT-8, 20, and 50 in fetal liver and placenta, but not fetal brain, was shown using radioactivity and TEM	Huang et al. (2014)74)
Intraperitoneal injection	MWCNT	o-MWCNTs (D: 10-30 nm, L: 1-2 mm, purity496%, Shenzehen Nanotech, Shenzehen, China) in saline 99mTc-o-MWCNTs in saline	Kunming mouse (10/group)	GD 7 until abortion or parturition GDs 4, 11, and 15 GDs 9-11 GD 17	20 mg/kg/d	Increased abortion rate and estradiol level in maternal sera at GDs 7 and 14, presence of ROS in the placentas of first-time pregnant mice Decreased maternal body weight gain and progesterone level in maternal sera at GDs 7, 14, 18, placental VEGF in first- and second-time pregnant mice In dams, 99mTc-oMWCNTs principally distributed in the lungs, followed by the liver, spleen, and kidney Accumulation was high in placenta 1 h after injection and peaked in placenta and fetus 6 h after injection	Qi et al. (2014)75)
Oral gavage	MWCNT	CM-95, D: 10-15 nm, L: 20 mm, 95% C, 5% Fe, (Hanwha Nanotech, Seoul, South Korea) in 1% CMC solution	SD rat (12/group)	GDs 6-19 (sperm¼GD 0)	8, 40, 200, 1000 mg/kg/d	Decreased maternal thymus weight at 1000 mg No effect on fetal growth, viability, or morphological development	Lim et al. (2011)76,77)
Oral gavage	MWCNT	COOH-MWCNTs (D inner/outer: 20 nm/30 nm, L: 0.5-2.0 mm)	CD1 mouse (10/group)	GD 0-21 d after delivery (vaginal plug¼GD 0)	22, 65 mg/ kg/d	No effect on litter size, sex ratio of pups, or body or organ weight, or serum levels of malondialdehyde, FSH, LH, or testosterone of male offspring	Wang et al. (2014)78)
Intraperitoneal injection	SWCNT	PEG-SWCNTs (L: 86 nm, low content of metals, carbon solution) in PBS	CD1 mouse (5-18/group)	GD 5.5 (vaginal plug¼GD 0.5) GD 14.5 GDs 5.5, 8.5, 11.5	0.1, 10, 30 mg 10 mg 10 mg/d	One fetus with external malformations in 1/10 dams after injection of 30 mg at GD 5,5 and a total of five fetuses with external malformations in 2/10 dams after multiple injections PEG-SWCNT-750 localized in implantation sites after injection on GD 5.5 and in placenta and yolk sac (but not embryos) after injection on GD 14.5 Size, vascularization of the labyrinth layer, and expression of CD31 in placentas of malformed fetuses Hepatic changes in dams after multiple injections	Campagnolo et al. (2013)79)
Intraperitoneal injection	SWCNT	p-SWCNTs; o-SWCNTs; uo-SWCNTs in DMEM containing BSA	CD1 mouse (16-23/group)	GD 5.5	0.01, 0.1, 0.3, 3, 30 mg	Maternal incidence of miscarriage at 30 mg of p-, o-, and uo-SWCNTs; Incidence of dams with malformed fetuses after 3 mg of p-SWCNTs, 30 mg of o-SWCNTs, and 0.3 mg of uo-SWCNTs; ROS in malformed fetuses and their placentas for uo-SWCNTs group	Pietroiusti et al. (2011)81)
Intraperitoneal injection	SWCNT	PL-PEG-NH4-SWCNTs (D: 1-2 nm, L: 0.5-2 mm) in water 64Cu-labeled PL-PEG-NH4-SWCNTs (functionalization with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino (polyethylene glycol)-2000]) in water	p53+/- mouse (4-6/group)	GDs 10.5, 12.5, 15.5 GD 15.5	2 mg/kg/d	No effect on maternal or fetal body weight, or incidence of fetal deformities. Distribution of SWCNTs to fetal liver and placenta, but not brain, was shown by radioactivity and TEM	Huang et al. (2014)74)
Oral gavage	SWCNT	FOH-SWCNTs (size: 45-138 nm) in 0.5% tragacanth gum solution	CD1 mouse (10-12/group)	GD 9 (vaginal plug¼GD 1)	10, 100 mg/kg	Incidences of resorptions and fetuses with gross or skeletal anomalies at 10 mg/kg (but not 100 mg/kg)	Philbrook et al. (2011)80)
GD, gestation day

Transient histopathological changes were reported in mice after intravenous injection of MWCNTs in adulthood⁷⁰⁾. A delay in the delivery of the first litter was observed after intratracheal instillation in the female prior to mating⁷¹⁾. Administration of MWCNTs in pregnant mice induced fetal malformations after intraperitoneal and intravenous injections and intratracheal instillation, miscarriage after intravenous injection, and effects on the offspring's central nervous system after intravenous and intraperitoneal injection^72,73). Moreover, developmental toxicity was also observed in mice intravenously injected with amine-functionalized MWCNTs⁷⁴⁾. There was an increase in the rate of miscarriage and estradiol in maternal sera. The abortifacient effect of oxidized-MWCNTs was observed in mice intravenously injected with a dose of 20 mg/kg/d⁷⁵⁾. In contrast, the oral administration of MWCNTs to dams was not associated with adverse effects on fetal development in rats or on female reproduction and offspring growth in mice^76-78).

Some pristine and functionalized SWCNTs appeared to be embryolethal and teratogenic when administered in mice via intravenous injection⁷⁹⁾ or oral gavage⁸⁰⁾. One study showed that developmental toxicity was dependent on SWCNT functionalization⁸¹⁾. SWCNTs may also increase the production of ROS which may be involved in developmental toxicity, possibly due to placental effects. It was, however, unclear whether ROS levels was generally increased in the placentas of exposed dams or only in affected embryos/fetuses. Placental transfer of SWCNTs was reported after intravenous injection during late gestation in p53+/- mice, but not in CD1 mice⁷⁴⁾.

Overall data on the reproductive and developmental toxicity of CNTs are limited, and interpretation in some cases was hampered by the applied study designs, including a lack of control for potential litter effects as well as the characterization of the CNTs in suspension. Studies on male and female reproduction and further developmental toxicity following exposure via the anticipated route of human exposure are required in order to elucidate the reproductive and developmental toxicities of CNTs.

Conflicts of interest: The authors declare that there are no conflicts of interest.

References

• 1)   Morimoto  Y,  Kobayashi  N,  Shinohara  N,  Myojo  T,  Tanaka  I,  Nakanishi  J. Hazard assessments of manufactured nanomaterials. J Occup Health 2010; 52: 325-334.
• 2)   Morimoto  Y,  Horie  M,  Kobayashi  N,  Shinohara  N,  Shimada  M. Inhalation toxicity assessment of carbon-based nanoparticles. Acc Chem Res 2013; 46: 770-781.
• 3)   Takagi  A,  Hirose  A,  Nishimura  T, et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 2008; 33: 105-116.
• 4)   Lin  B,  Zhang  H,  Lin  Z, et al. Studies of single-walled carbon nanotubes-induced hepatotoxicity by NMR-based metabonomics of rat blood plasma and liver extracts. Nanoscale Res Lett 2013; 8: 236.
• 5)   Zheng  W,  McKinney  W,  Kashon  M,  Salmen  R,  Castranova  V,  Kan  H. The influence of inhaled multi-walled carbon nanotubes on the autonomic nervous system. Part Fibre Toxicol 2016; 13: 8.
• 6)   Ema  M,  Hougaard  KS,  Kishimoto  A,  Honda  K. Reproductive and developmental toxicity of carbon-based nanomaterials: A literature review. Nanotoxicology 2016; 10: 391-412.
• 7)   Borm  PJ,  Driscoll  K. Particles, inflammation and respiratory tract carcinogenesis. Toxicol Lett 1996; 88: 109-113.
• 8)   Shacter  E,  Weitzman  SA. Chronic inflammation and cancer. Oncology (Williston Park) 2002; 16: 217-229.
• 9)   Nishi  K,  Morimoto  Y,  Ogami  A, et al. Expression of cytokine-induced neutrophil chemoattractant in rat lungs by intratracheal instillation of nickel oxide nanoparticles. Inhal Toxicol 2009; 21: 1030-1039.
• 10)   Ogami  A,  Morimoto  Y,  Myojo  T, et al. Histopathological changes in rat lung following intratracheal instillation of silicon carbide whiskers and potassium octatitanate whiskers. Inhal Toxicol 2007; 19: 753-758.
• 11)   Mitchell  LA,  Gao  J,  Wal  RV,  Gigliotti  A,  Burchiel  SW,  McDonald  JD. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci 2007; 100: 203-214.
• 12)   Mitchell  LA,  Lauer  FT,  Burchiel  SW,  McDonald  JD. Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat Nanotechnol 2009; 4: 451-456.
• 13)   Ma-Hock  L,  Treumann  S,  Strauss  V, et al. Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol Sci 2009; 112: 468-481.
• 14)   Pauluhn  J. Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol Sci 2010; 113: 226-242.
• 15)   Delorme  MP,  Muro  Y,  Arai  T, et al. Ninety-day inhalation toxicity study with a vapor grown carbon nanofiber in rats. Toxicol Sci 2012; 128: 449-460.
• 16)   Morimoto  Y,  Hirohashi  M,  Ogami  A, et al. Pulmonary toxicity of well-dispersed multi-wall carbon nanotubes following inhalation and intratracheal instillation. Nanotoxicology 2012; 6: 587-599.
• 17)   Morimoto  Y,  Hirohashi  M,  Kobayashi  N, et al. Pulmonary toxicity of well-dispersed single-wall carbon nanotubes after inhalation. Nanotoxicology 2012; 6: 766-775.
• 18)   Kasai  T,  Umeda  Y,  Ohnishi  M, et al. Thirteen-week study of toxicity of fiber-like multi-walled carbon nanotubes with whole-body inhalation exposure in rats. Nanotoxicology 2015; 9: 413-422.
• 19)   Warheit  DB,  Laurence  BR,  Reed  KL,  Roach  DH,  Reynolds  GA,  Webb  TR. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 2004; 77: 117-125.
• 20)   Muller  J,  Huaux  F,  Moreau  N, et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 2005; 207: 221-231.
• 21)   Chou  CC,  Hsiao  HY,  Hong  QS, et al. Single-walled carbon nanotubes can induce pulmonary injury in mouse model. Nano Lett 2008; 8: 437-445.
• 22)   Crouzier  D,  Follot  S,  Gentilhomme  E, et al. Carbon nanotubes induce inflammation but decrease the production of reactive oxygen species in lung. Toxicology 2010; 272: 39-45.
• 23)   Elgrabli  D,  Abella-Gallart  S,  Robidel  F,  Rogerieux  F,  Boczkowski  J,  Lacroix  G. Induction of apoptosis and absence of inflammation in rat lung after intratracheal instillation of multiwalled carbon nanotubes. Toxicology 2008; 253: 131-136.
• 24)   Park  EJ,  Cho  WS,  Jeong  J,  Yi  J,  Choi  K,  Park  K. Pro-inflammatory and potential allergic responses resulting from B cell activation in mice treated with multi-walled carbon nanotubes by intratracheal instillation. Toxicology 2009; 259: 113-121.
• 25)   Aiso  S,  Yamazaki  K,  Umeda  Y, et al. Pulmonary toxicity of intratracheally instilled multiwall carbon nanotubes in male Fischer 344 rats. Ind Health 2010; 48: 783-795.
• 26)   Han  SG,  Andrews  R,  Gairola  CG. Acute pulmonary response of mice to multi-wall carbon nanotubes. Inhal Toxicol 2010; 22: 340-347.
• 27)   Kobayashi  N,  Naya  M,  Ema  M, et al. Biological response and morphological assessment of individually dispersed multi-wall carbon nanotubes in the lung after intratracheal instillation in rats. Toxicology 2010; 276: 143-153.
• 28)   Kobayashi  N,  Naya  M,  Mizuno  K,  Yamamoto  K,  Ema  M,  Nakanishi  J. Pulmonary and systemic responses of highly pure and well-dispersed single-wall carbon nanotubes after intratracheal instillation in rats. Inhal Toxicol 2011; 23: 814-828.
• 29)   Morimoto  Y,  Hirohashi  M,  Horie  M, et al. Pulmonary toxicity of well-dispersed single-wall carbon nanotubes following intratracheal instillation. J Nano Res 2012; 18: 9-25.
• 30)   Murray  AR,  Kisin  ER,  Tkach  AV, et al. Factoring-in agglomeration of carbon nanotubes and nanofibers for better prediction of their toxicity versus asbestos. Part Fibre Toxicol 2012; 9: 10.
• 31)   Fujita  K,  Fukuda  M,  Fukui  H, et al. Intratracheal instillation of single-wall carbon nanotubes in the rat lung induces time-dependent changes in gene expression. Nanotoxicology 2015; 9: 290-301.
• 32)   Porter  DW,  Hubbs  AF,  Mercer  RR, et al. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010; 269: 136-147.
• 33)   Mercer  RR,  Hubbs  AF,  Scabilloni  JF, et al. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol 2011; 8: 21.
• 34)   Shvedova  AA,  Kisin  ER,  Mercer  R, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005; 289: L698-L708.
• 35)   Shvedova  AA,  Kisin  ER,  Murray  AR, et al. Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. Toxicol Appl Pharmacol 2007; 221: 339-348.
• 36)   Shvedova  AA,  Kisin  E,  Murray  AR, et al. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol 2008; 295: L552-L565.
• 37)   Sager  TM,  Wolfarth  MW,  Battelli  LA, et al. Investigation of the pulmonary bioactivity of double-walled carbon nanotubes. J Toxicol Environ Health A 2013; 76: 922-936.
• 38)   Pothmann  D,  Simar  S,  Schuler  D, et al. Lung inflammation and lack of genotoxicity in the comet and micronucleus assays of industrial multiwalled carbon nanotubes Graphistrength((c)) C100 after a 90-day nose-only inhalation exposure of rats. Part Fibre Toxicol 2015; 12: 21.
• 39)   Silva  RM,  Doudrick  K,  Franzi  LM, et al. Instillation versus inhalation of multiwalled carbon nanotubes: exposure-related health effects, clearance, and the role of particle characteristics. ACS Nano 2014; 8: 8911-8931.
• 40)   Lam  CW,  James  JT,  McCluskey  R,  Hunter  RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004; 77: 126-134.
• 41)   van Berlo  D,  Wilhelmi  V,  Boots  AW, et al. Apoptotic, inflammatory, and fibrogenic effects of two different types of multi-walled carbon nanotubes in mouse lung. Arch Toxicol 2014; 88: 1725-1737.
• 42)   Chen  T,  Nie  H,  Gao  X, et al. Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway. Toxicol Lett 2014; 226: 150-162.
• 43)   Wang  P,  Nie  X,  Wang  Y, et al. Multiwall carbon nanotubes mediate macrophage activation and promote pulmonary fibrosis through TGF-beta/Smad signaling pathway. Small 2013; 9: 3799-3811.
• 44)   Fujita  K,  Fukuda  M,  Endoh  S, et al. Pulmonary and pleural inflammation after intratracheal instillation of short single-walled and multi-walled carbon nanotubes. Toxicol Lett 2016; 257: 23-37.
• 45)   Roda  E,  Coccini  T,  Acerbi  D,  Barni  S,  Vaccarone  R,  Manzo  L. Comparative pulmonary toxicity assessment of pristine and functionalized multi-walled carbon nanotubes intratracheally instilled in rats: morphohistochemical evaluations. Histol Histopathol 2011; 26: 357-367.
• 46)   Frank  EA,  Carreira  VS,  Birch  ME,  Yadav  JS. Carbon nanotube and asbestos exposures induce overlapping but distinct profiles of lung pathology in non-swiss Albino CF-1 mice. Toxicol Pathol 2016; 44: 211-225.
• 47)   Xu  J,  Futakuchi  M,  Shimizu  H, et al. Multi-walled carbon nanotubes translocate into the pleural cavity and induce visceral mesothelial proliferation in rats. Cancer Sci 2012; 103: 2045-2050.
• 48)   Chang  CC,  Tsai  ML,  Huang  HC,  Chen  CY,  Dai  SX. Epithelial-mesenchymal transition contributes to SWCNT-induced pulmonary fibrosis. Nanotoxicology 2012; 6: 600-610.
• 49)   Antoniou  KM,  Tomassetti  S,  Tsitoura  E,  Vancheri  C. Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update. Curr Opin Pulm Med 2015; 21: 626-633.
• 50)  IARC Working group on the evaluation of carcinogenic risks to humans. Man-made vitreous fibres. 4. Other data relevant to an evaluation of carcinogenicity and its mechanism. IARC Monogr Eval Carcinog Risks Hum 2002; 81: 241-326.
• 51)   Poland  CA,  Duffin  R,  Kinloch  I, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008; 3: 423-428.
• 52)   Mercer  RR,  Scabilloni  JF,  Hubbs  AF, et al. Distribution and fibrotic response following inhalation exposure to multi-walled carbon nanotubes. Part Fibre Toxicol 2013; 10: 33.
• 53)   Shinohara  N,  Nakazato  T,  Ohkawa  K, et al. Long-term retention of pristine multi-walled carbon nanotubes in rat lungs after intratracheal instillation. J Appl Toxicol 2016; 36: 501-509.
• 54)   Oyabu  T,  Myojo  T,  Morimoto  Y, et al. Biopersistence of inhaled MWCNT in rat lungs in a 4-week well-characterized exposure. Inhal Toxicol 2011; 23: 784-791.
• 55)   Boulanger  G,  Andujar  P,  Pairon  JC, et al. Quantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity. Environ Health 2014; 13: 59.
• 56)   Osmond-McLeod  MJ,  Poland  CA,  Murphy  F, et al. Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres. Part Fibre Toxicol 2011; 8: 15.
• 57)   Kato  T,  Totsuka  Y,  Ishino  K, et al. Genotoxicity of multi-walled carbon nanotubes in both in vitro and in vivo assay systems. Nanotoxicology 2013; 7: 452-461.
• 58)   Catalan  J,  Siivola  KM,  Nymark  P, et al. In vitro and in vivo genotoxic effects of straight versus tangled multi-walled carbon nanotubes. Nanotoxicology 2016; 10: 794-806.
• 59)   Poulsen  SS,  Jackson  P,  Kling  K, et al. Multi-walled carbon nanotube physicochemical properties predict pulmonary inflammation and genotoxicity. Nanotoxicology 2016; 10: 1263-1275.
• 60)   Ema  M,  Masumori  S,  Kobayashi  N, et al. In vivo comet assay of multi-walled carbon nanotubes using lung cells of rats intratracheally instilled. J Appl Toxicol 2013; 33: 1053-1060.
• 61)   Horibata  K,  Ukai  A,  Ogata  A, et al. Absence of in vivo mutagenicity of multi-walled carbon nanotubes in single intratracheal instillation study using F344 gpt delta rats. Genes Environ 2017; 39: 4.
• 62)   Shvedova  AA,  Yanamala  N,  Kisin  ER, et al. Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year postexposure comparisons. Am J Physiol Lung Cell Mol Physiol 2014; 306: L170-L182.
• 63)   Rubio  L,  El Yamani  N,  Kazimirova  A,  Dusinska  M,  Marcos  R. Multi-walled carbon nanotubes (NM401) induce ROS-mediated HPRT mutations in Chinese hamster lung fibroblasts. Environ Res 2016; 146: 185-190.
• 64)   Kim  JS,  Yu  IJ. Single-wall carbon nanotubes (SWCNT) induce cytotoxicity and genotoxicity produced by reactive oxygen species (ROS) generation in phytohemagglutinin (PHA)-stimulated male human peripheral blood lymphocytes. J Toxicol Environ Health A 2014; 77: 1141-1153.
• 65)   Kasai  T,  Umeda  Y,  Ohnishi  M, et al. Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats. Part Fibre Toxicol 2016; 13: 53.
• 66)   Sargent  LM,  Porter  DW,  Staska  LM, et al. Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes. Part Fibre Toxicol 2014; 11: 3.
• 67)   Suzui  M,  Futakuchi  M,  Fukamachi  K, et al. Multiwalled carbon nanotubes intratracheally instilled into the rat lung induce development of pleural malignant mesothelioma and lung tumors. Cancer Sci 2016; 107: 924-935.
• 68)   Muller  J,  Delos  M,  Panin  N,  Rabolli  V,  Huaux  F,  Lison  D. Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol Sci 2009; 110: 442-448.
• 69)   Pauluhn  J. Poorly soluble particulates: searching for a unifying denominator of nanoparticles and fine particles for DNEL estimation. Toxicology 2011; 279: 176-188.
• 70)   Bai  Y,  Zhang  Y,  Zhang  J, et al. Repeated administrations of carbon nanotubes in male mice cause reversible testis damage without affecting fertility. Nat Nanotechnol 2010; 5: 683-689.
• 71)   Hougaard  KS,  Jackson  P,  Kyjovska  ZO, et al. Effects of lung exposure to carbon nanotubes on female fertility and pregnancy. A study in mice. Reprod Toxicol 2013; 41: 86-97.
• 72)   Fujitani  T,  Ohyama  K,  Hirose  A,  Nishimura  T,  Nakae  D,  Ogata  A. Teratogenicity of multi-wall carbon nanotube (MWCNT) in ICR mice. J Toxicol Sci 2012; 37: 81-89.
• 73)   Ivani  S,  Karimi  I,  Tabatabaei  SR. Biosafety of multiwalled carbon nanotube in mice: a behavioral toxicological approach. J Toxicol Sci 2012; 37: 1191-1205.
• 74)   Huang  X,  Zhang  F,  Sun  X, et al. The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development. Biomaterials 2014; 35: 856-865.
• 75)   Qi  W,  Bi  J,  Zhang  X, et al. Damaging effects of multi-walled carbon nanotubes on pregnant mice with different pregnancy times. Sci Rep 2014; 4: 4352.
• 76)   Lim  JH,  Kim  SH,  Shin  IS, et al. Maternal exposure to multi-wall carbon nanotubes does not induce embryo-fetal developmental toxicity in rats. Birth Defects Res B Dev Reprod Toxicol 2011; 92: 69-76.
• 77)   Lim  JH,  Kim  SH,  Lee  IC, et al. Evaluation of maternal toxicity in rats exposed to multi-wall carbon nanotubes during pregnancy. Environ Health Toxicol 2011; 26: e2011006.
• 78)   Wang  W,  Jiang  C,  Zhu  L, et al. Adsorption of bisphenol A to a carbon nanotube reduced its endocrine disrupting effect in mice male offspring. Int J Mol Sci 2014; 15: 15981-15993.
• 79)   Campagnolo  L,  Massimiani  M,  Palmieri  G, et al. Biodistribution and toxicity of pegylated single wall carbon nanotubes in pregnant mice. Part Fibre Toxicol 2013; 10: 21.
• 80)   Philbrook  NA,  Walker  VK,  Afrooz  AR,  Saleh  NB,  Winn  LM. Investigating the effects of functionalized carbon nanotubes on reproduction and development in Drosophila melanogaster and CD-1 mice. Reprod Toxicol 2011; 32: 442-448.
• 81)   Pietroiusti  A,  Massimiani  M,  Fenoglio  I, et al. Low doses of pristine and oxidized single-wall carbon nanotubes affect mammalian embryonic development. ACS Nano 2011; 5: 4624-4633.